Literature DB >> 17931357

Development of spontaneous optic neuropathy in NF-kappaBetap50-deficient mice: requirement for NF-kappaBetap50 in ganglion cell survival.

Y Takahashi1, N Katai, T Murata, S-I Taniguchi, T Hayashi.   

Abstract

Although the transcription factor NF-kappaBeta is known to regulate cell death and survival, its precise role in cell death within the central nervous system remains unknown. The purpose of this study was to investigate the role of NF-kappaBetap50 in the age-related survival of retinal ganglion cells (RGCs). Eyes of mice with a deleted NF-kappaBetap50 gene and its wild-type mice at each of age were studied by histopathological studies. The number of RGCs was counted using retrograde labelling methods. Mice were subjected to intravitreous injection of N-methyl-D aspartate (NMDA) to induce RGC death. In p50-deficient mice, the number of RGCs significantly decreased with age in total independence of intraocular pressure measurement. Optic nerves of p50-deficient mice showed hypertrophy astrocytes and enlargement of the axons, together with a decreased number of axons. Immunohistochemistry showed a strong expression of glial fibrillary acidic protein. The histological results show obvious excavation of the optic nerve head in p50-deficient mice at 10 months of age. Intravitreal injection of NMDA in young p50-deficient mice damaged RGCs more intensively than in control animals. We further noticed that autoantibodies against RGCs were produced in p50-deficient mice. Our results show that p50 deficiency induced age-related RGC death, indicating a new insight into the role of p50 in the pathophysiology of neuropathy, and further experiments with p50-deficient mice may provide new targets for therapeutic intervention for human glaucoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931357     DOI: 10.1111/j.1365-2990.2007.00862.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  15 in total

1.  Deletion of Nuclear Factor kappa B p50 Subunit Decreases Inflammatory Response and Mildly Protects Neurons from Transient Forebrain Ischemia-induced Damage.

Authors:  Taisia Rolova; Hiramani Dhungana; Paula Korhonen; Piia Valonen; Natalia Kolosowska; Henna Konttinen; Katja Kanninen; Heikki Tanila; Tarja Malm; Jari Koistinaho
Journal:  Aging Dis       Date:  2015-11-23       Impact factor: 6.745

2.  Astroglial NF-κB mediates oxidative stress by regulation of NADPH oxidase in a model of retinal ischemia reperfusion injury.

Authors:  David J Barakat; Galina Dvoriantchikova; Dmitry Ivanov; Valery I Shestopalov
Journal:  J Neurochem       Date:  2012-01-04       Impact factor: 5.372

3.  Network analysis of human glaucomatous optic nerve head astrocytes.

Authors:  Tatiana Nikolskaya; Yuri Nikolsky; Tatiana Serebryiskaya; Svetlana Zvereva; Eugene Sviridov; Zoltan Dezso; Eugene Rahkmatulin; Richard J Brennan; Nick Yankovsky; Sanjoy K Bhattacharya; Olga Agapova; M Rosario Hernandez; Valery I Shestopalov
Journal:  BMC Med Genomics       Date:  2009-05-09       Impact factor: 3.063

4.  In vivo imaging of optic nerve fiber integrity by contrast-enhanced MRI in mice.

Authors:  Stefanie Fischer; Christian Engelmann; Karl-Heinz Herrmann; Jürgen R Reichenbach; Otto W Witte; Falk Weih; Alexandra Kretz; Ronny Haenold
Journal:  J Vis Exp       Date:  2014-07-22       Impact factor: 1.355

Review 5.  From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma.

Authors:  David Križaj; Daniel A Ryskamp; Ning Tian; Gülgün Tezel; Claire H Mitchell; Vladlen Z Slepak; Valery I Shestopalov
Journal:  Curr Eye Res       Date:  2013-10-21       Impact factor: 2.424

Review 6.  Immune regulation toward immunomodulation for neuroprotection in glaucoma.

Authors:  Gülgün Tezel
Journal:  Curr Opin Pharmacol       Date:  2012-10-19       Impact factor: 5.547

7.  Immunomodulation as a Neuroprotective Strategy for Glaucoma Treatment.

Authors:  Mine Bariş; Gülgün Tezel
Journal:  Curr Ophthalmol Rep       Date:  2019-04-23

8.  Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.

Authors:  Ananthamurthy Nagabhushana; Megha Bansal; Ghanshyam Swarup
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

9.  Development of spontaneous neuropathy in NF-κBp50-deficient mice by calcineurin-signal involving impaired NF-κB activation.

Authors:  Tomoko Nakamura-Yanagidaira; Yasuko Takahashi; Kenji Sano; Toshinori Murata; Takuma Hayashi
Journal:  Mol Vis       Date:  2011-08-11       Impact factor: 2.367

10.  NF-kappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NF-kappaB.

Authors:  Cherukuri Sudhakar; Ananthamurthy Nagabhushana; Nishant Jain; Ghanshyam Swarup
Journal:  PLoS One       Date:  2009-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.